LivingGLP1
Study S000215

LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY

Registration

Registration
NCT01597531
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
TERMINATED
Enrollment
1
Start
2012-06
Primary completion
2014-06
Lead sponsor
East Carolina University
Conditions
Type 2 Diabetes; Gastric Banding
Interventions
DRUG:Liraglutide; DRUG:Orlistat; DRUG:Liraglutide + Orlistat
Results posted
FALSE

Registered primary outcomes

  • Type 2 diabetes remission [baseline, 1 and 4 months post-randomization]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.